Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Healthcor Management Reduces Position in Allscripts Healthcare Solutions Inc (MDRX)

Arthur Cohen and Joseph Healey‘s Healthcor Management, revealed, in a newly amended filing with the SEC, decreasing its holding in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), currently owning 10.0 million shares of the company, from 11.0 million held at the end of September, as revealed in the fund’s latest 13F. Currently Healthcor’s activist stake, amasses 5.6% of the company’s common stock, and at the current value of Allscripts Healthcare Solutions shares, it is worth $150.2 million.

Arthur B Cohen and Joseph Healey

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) makes it easy for healthcare experts to generate world-class outcomes through its insightful connectivity and information solutions. The company has recently announced the expansion of its operations in India, one of its key emerging markets, through opening a new product development center in Baroda. The facility is expected to help the company to consolidate its product development team, the company said in a statement. In this way, Allscripts’ center in Baroda will have a team consisting of around 400 employees, up from the current 275.

Several hedge funds have been bullish on Allscripts so far. Despite trimming the holding, Healthcor Management is still one of the most significant stockholders of the company. Eminence Capital, managed by Ricky Sandler, is another holder of a large position, revealing ownership of almost 7.8 million shares, worth $115.8 million in its latest 13F. It is followed by Clifton S. Robbins‘ Blue Harbour Group, which disclosed a $108 million stake, which amasses 7.3 million shares.

According to another recent filing of Healthcor Management, the fund has initiated a passive stake in Five Prime Therapeutics Inc (NASDAQ:FPRX), owning currently 965,000 shares, equal to 5.73% of the outstanding common stock.

Disclosure: none

Recommended Reading:

Jeff Smith, Starboard Value Add to Position in Office Depot Inc (ODP)

Zac Hirzel Gets Appointed to the Board of Hawaiian Holdings, Inc. (HA)

Bill Gates’ Cascade Investment Acquires a Resort from Strategic Hotels and Resorts Inc (BEE)

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!